Synthesis of luminescent Zn(II) complexes improves emission properties in mono- and bis-imidazo[1,5-a]pyridine ligands, highlighting design potential.
A new series of luminescent Zn(II) complexes based on mono- and bis-imidazo[1,5-a]pyridine ligands was synthesized to investigate the correlation between structural modifications and photophysical behaviour. Systematic variations in substituent groups, coordination geometry, and π-conjugation extent enabled precise tuning of absorption and emission properties. Spectroscopic analysis revealed that Zn(II) coordination enhances molecular rigidity and induces a conformational change in the ligands, resulting in improved quantum yields (up to 37%) and significant blue shifts in emission. Notably, in bis-ligand systems, each imidazo[1,5-a]pyridine unit retains its distinct emissive signature upon complexation, demonstrating their optical and electronic independence. This modular behaviour confirms that individual emissive centres can be predictably manipulated without mutual interference, offering a powerful design strategy for multichromophoric materials. Structural, vibrational, and mass spectrometric characterizations further corroborate the stability and coordination patterns of the synthesized complexes. These insights lay the groundwork for engineering efficient and tunable Zn(II)-based luminophores for applications in optoelectronics, sensing, and bioimaging.
No takes yet. Share an insight, caveat, or question.
Volpi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: